The initiative is called the American COVID-19 Collaborative Enabling Seamless Science, or ACCESS, and in addition to Medable, it includes BioIntelliSense, Datavant, Parexel, PWNHealth, and the American Heart Association's Center for Health Technology and Innovation. ACCESS facilitates at-home research, clinical trial access, and population-based long-term outcome studies.

Via a mobile app, it connects researchers and clinical trial teams with homebound patients in the U.S., Medable said. Patients can contribute information about their COVID-19 experience, which can then be combined with their health records. Patients can also opt to participate in clinical studies.

ACCESS also provides screening, disease and immunity status testing, and general lab testing through PWNHealth, and it offers researchers access to anonymized health records, claims, and diagnostic data through Datavant, Medable said.

Illumina makes SARS-CoV-2 NGS toolkit free of charge
Illumina is making its SARS-CoV-2 data toolkit, a suite of data analysis tools and workflow functionality, free for researchers researching the virus...

Loop Genomics debuts SARS-CoV-2 sequencing service
Loop Genomics has launched a new service for long-read sequencing of long amplicons of SARS-CoV-2, the virus that causes COVID-19.

The jury is still out for SARS-CoV-2 intermediate host
Scientists have been searching for the intermediate host between bats, which are known to carry coronaviruses, and the first introduction of SARS-CoV-2...

BioInformatics releases more results from COVID-19 lab tracker survey
Scientists whose labs have been closed due to the COVID-19 pandemic are spending their time writing and planning future research projects, according to...

Scripps Research expands drug repurposing efforts for COVID-19
Scripps Research has pivoted its drug repurposing collection ReFRAME to find antiviral compounds effective against the novel coronavirus.